Bird & Bird Nordic offices maintain strong rankings in IFLR1000 2023 edition

International law firm Bird & Bird is pleased to announce that our Nordic offices have achieved commendable rankings in the esteemed IFLR1000 2023 edition. IFLR1000 is a respected international legal market research product known for its comprehensive assessment and ranking of financial and corporate law firms and lawyers.

The IFLR1000 2023 rankings reaffirm our commitment to delivering exceptional legal services to our clients across the Nordic region. Our rankings are as follows:

Sweden

Capital Markets: Equity: Tier 3
M&A: Tier 3
Project Development: Notable

Finland

Capital Markets: Equity: Tier 2
Banking & Finance: Tier 3
M&A: Tier 3
Capital Markets: Debt: Tier 4
Project Development: Notable

Denmark

M&A: Tier 3
Banking and Finance: Notable

We are also immensely proud of our talented team of ranked practitioners. Their dedication to delivering exceptional service and legal acumen has been instrumental in earning these accolades. The ranked practitioners in our Nordic offices include:

Jori Taipale
Highly regarded – Banking, M&A, Private equity

Laura Huomo
Highly regarded – Capital markets

Morten Rosenmejer
Highly regarded – M&A

Maria Carlsson
Notable practioner – M&A

Mikko Ahonen
Notable practioner – M&A

Mårten Willamo
Notable practioner – M&A

Mika Puurunen
Rising star partner – Capital markets: Equity

For any financial, corporate, and capital markets related inquiries or issues, we invite you to contact our experienced professionals. Whether you require legal advice, consultation, or representation, our team is ready to assist you.

You can find the full IFLR1000 2023 results here.

News & Deals

More News & Deals

Deal

Bird & Bird advises World of Women on its transaction to join the Tezos ecosystem

Jul 23 2024

Read More

Deal

Bird & Bird advised EIFFEL GAZ VERT on an investment in the biogas sector

Jul 23 2024

Read More

News

Bird & Bird grows its Finance practice in Italy with the arrival of two new partners

Jul 19 2024

Read More

Deal

Bird & Bird has advised Dopay on its $13.5 million Series A Extension round

Jul 19 2024

Read More

News

Bird & Bird advises iX Biopharma on rights issue

Jul 15 2024

Read More

Deal

Bird & Bird advises HSS on SciRhom’s EUR 63 million Series A financing round

Jul 11 2024

Read More